Mirati Therapeutics Company Profile (NASDAQ:MRTX)

Analyst Ratings

Consensus Ratings for Mirati Therapeutics (NASDAQ:MRTX) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $22.88 (386.70% upside)

Analysts' Ratings History for Mirati Therapeutics (NASDAQ:MRTX)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Barclays PLCLower Price TargetOverweight$41.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Leerink SwannDowngradeOutperform -> Market Perform$37.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Citigroup Inc.Lower Price TargetBuy$30.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Jefferies GroupDowngradeBuy -> Hold$27.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016WedbushLower Price TargetOutperform$29.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Piper Jaffray Cos.Initiated CoverageHold$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Avondale PartnersUpgradeMarket Perform -> Market Outperform$22.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016SunTrust Banks Inc.Initiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Brean CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Mirati Therapeutics (NASDAQ:MRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1($0.99)($1.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q4($1.03)($0.96)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015($0.88)($1.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015($0.71)($0.77)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414($0.83)($0.77)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.76)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2014Q214($0.69)($0.82)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/18/2014Q413($0.66)($0.97)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313($0.78)($2.95)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mirati Therapeutics (NASDAQ:MRTX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($1.19)($0.90)($1.01)
Q2 20165($1.21)($1.00)($1.08)
Q3 20165($1.22)($1.02)($1.10)
Q4 20165($1.22)($0.91)($1.03)
Q1 20171($1.08)($1.08)($1.08)
Q2 20171($1.10)($1.10)($1.10)
Q3 20171($1.12)($1.12)($1.12)
Q4 20171($1.16)($1.16)($1.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mirati Therapeutics (NASDAQ:MRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirati Therapeutics (NASDAQ:MRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016Charles M BaumCEOBuy20,000$7.05$141,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Bros. Advisors Lp BakerMajor ShareholderSell999,358$9.41$9,403,958.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Ltd. BraslynMajor ShareholderBuy376,902$9.96$3,753,943.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Ltd. BraslynMajor ShareholderBuy65,782$18.21$1,197,890.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2016Ltd. BraslynMajor ShareholderBuy20,848$19.36$403,617.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Ltd. BraslynMajor ShareholderBuy1,166$19.34$22,550.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Mark J. GergenCOOSell10,000$25.92$259,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2015Bros. Advisors Lp BakerMajor ShareholderBuy150,000$45.00$6,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Jamie ChristensenSVPSell4,750$28.07$133,332.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Jamie ChristensenSVPSell6,000$25.41$152,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Jamie ChristensenSVPSell4,750$22.84$108,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Orbimed Advisors LlcMajor ShareholderBuy100,000$20.00$2,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Bros. Advisors Lp BakerMajor ShareholderBuy425,000$20.00$8,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Orbimed Advisors LlcMajor ShareholderSell107,332$21.66$2,324,811.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Charles M BaumCEOBuy5,000$16.96$84,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Orbimed Advisors LlcMajor ShareholderBuy125,000$17.50$2,187,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Tang Capital Partners LpMajor ShareholderBuy57,143$17.50$1,000,002.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Tang Capital Partners LpMajor ShareholderSell36,898$16.34$602,913.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mirati Therapeutics (NASDAQ:MRTX)
DateHeadline
07/22/16 08:15 AMNew Broker Ratings For Mirati Therapeutics, Inc. (MRTX) - FTSE News
07/22/16 08:15 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 20 Session - Equities.com
07/21/16 03:04 PMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers -
07/21/16 08:08 AMMirati Therapeutics Inc. (MRTX) Drops 6.37% on July 19 - Equities.com
07/21/16 08:08 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 19 Session - Equities.com
07/20/16 06:00 PMIs $32 Price Target Attainable For Mirati Therapeutics, Inc. (NASDAQ:MRTX)? - Investor Newswire
07/20/16 05:59 PMIs Selling Stock Like Mirati Therapeutics, Inc. After Such Decline Winning Strategy? - Press Telegraph
07/18/16 10:05 AM10 Battered Biotech Stocks That Hit 52-Week Lows Friday -
07/17/16 09:34 AMVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Consumer Eagle
07/17/16 09:34 AMShares Moving Down on the Week: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Engelwood Daily
07/16/16 08:38 AMShares Experiencing a Downtrend: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - TGP
07/16/16 08:38 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During July 14 Session - Equities.com
07/15/16 04:20 PMIncreased Volatility Noted on Shares of: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Engelwood Daily
07/15/16 04:20 PMMirati Therapeutics Incorporated (NASDAQ:MRTX) Shorted Shares Increased 28.48% After Market Selling - Consumer Eagle
07/15/16 09:49 AMMirati Therapeutics, Inc. Just Reaches All-Time Low? - Press Telegraph
07/14/16 05:31 PMMirati Therapeutics Inc. (MRTX) Drops 5.4% on July 13 - Equities.com
07/14/16 08:53 AMBroker Outlook For Mirati Therapeutics, Inc. (MRTX) - Fiscal Standard
07/12/16 09:38 AMStock Volatility Focus for: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Engelwood Daily
07/12/16 09:38 AMMirati Therapeutics Incorporated (NASDAQ:MRTX) Short Interest Increased By 28.48% - Consumer Eagle
07/12/16 09:38 AMStrong Sell Calls For Mirati Therapeutics, Inc. (NASDAQ:MRTX) At 0 - Investor Newswire
07/12/16 09:38 AMMirati Therapeutics, Inc. (MRTX) Broker Price Targets For The Coming Week - Fiscal Standard
07/06/16 05:32 PMCan Mirati Therapeutics, Inc. (NASDAQ:MRTX) Improve on the Earnings Front? - Engelwood Daily
07/01/16 05:18 PMMirati Therapeutics Incorporated (NASDAQ:MRTX) Short Interest Increased By 28.48% - Engelwood Daily
07/01/16 05:18 PMInvestor News: Mirati Therapeutics, Inc. (NASDAQ:MRTX) under Investigation over possible Violations of Securities Laws - GroundReport
07/01/16 05:18 PMShares Entering Oversold Territory: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Press Telegraph
07/01/16 05:18 PMVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Press Telegraph
07/01/16 05:18 PMMirati Therapeutics, Inc. (MRTX) Current Analyst Ratings - Fiscal Standard
06/30/16 05:38 PMBiotech's Top 5 Losers, and Winners, From Q2 2016
06/30/16 05:38 PMMirati Therapeutics : Announces Change In Executive Leadership
06/29/16 05:10 PMInvestor News: Mirati Therapeutics, Inc. (NASDAQ:MRTX) under Investigation over possible Violations of Securities Laws
06/28/16 10:07 AMCovering the Bases on Mirati Therapeutics, Inc. (NASDAQ:MRTX): Where is the Stock Going? - Press Telegraph
06/28/16 10:07 AMStrong Sell Calls Recommendations For Mirati Therapeutics, Inc. (NASDAQ:MRTX) At 0 - Investor Newswire
06/25/16 09:03 AMVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Engelwood Daily
06/24/16 05:14 PMStock in Oversold Area: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Press Telegraph
06/24/16 05:14 PMHow Many Mirati Therapeutics, Inc. (NASDAQ:MRTX)'s Analysts Are Bearish? - Engelwood Daily
06/23/16 05:46 PMFrontline Trades in Focus: American Express (NYSE:AXP), Mirati Therapeutics (NASDAQ:MRTX), Diamondrock ... - Seneca Globe
06/23/16 05:46 PMMirati Therapeutics, Inc. (NasdaqCM:MRTX) Stock Momentum Hits EXTREME Weakness - CML News
06/23/16 05:46 PMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 20 Session - Equities.com
06/23/16 05:46 PMMirati Therapeutics (MRTX) COO to Step Down - StreetInsider.com
06/23/16 05:46 PMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 21 Session - Equities.com
06/22/16 05:09 PMCOO Mark Gergen Leaving Mirati Therapeutics
06/22/16 03:19 PMMirati Therapeutics Announces Change In Executive Leadership - [at noodls] - SAN DIEGO, June 22, 2016 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that Mark Gergen will step down as Executive Vice President and Chief Operations Officer to pursue other ...
06/22/16 03:02 PMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh -
06/22/16 03:02 PM4:02 pm Mirati Therapeutics announces Mark Gergen will step down as COO to pursue other opportunities -
06/18/16 09:35 AMInsider Buys with dollar amount more than $100 thousand: Mirati Therapeutics Inc.
06/18/16 09:35 AMInsider Buys of More Than $–……,………: Mirati Therapeutics
06/17/16 08:03 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 14 Session - Equities.com
06/16/16 06:12 PMInsider Buys of More Than $aaa,aaa: Mirati Therapeutics -
06/16/16 03:03 PMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ -
06/15/16 09:52 AMTwo Stocks within Traders Limelight: Mirati Therapeutics, Inc. (NASDAQ:MRTX) , Keryx Biopharmaceuticals, Inc ... - Street Updates

Social

About Mirati Therapeutics

Mirati Therapeutics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MRTX
  • CUSIP:
Key Metrics:
  • Previous Close: $4.70
  • 50 Day Moving Average: $6.30
  • 200 Day Moving Average: $17.19
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $93.56M
  • Beta: 1.42
  • Current Year EPS Consensus Estimate: $-4.55 EPS
  • Next Year EPS Consensus Estimate: $-4.42 EPS
Additional Links:
Mirati Therapeutics (NASDAQ:MRTX) Chart for Tuesday, July, 26, 2016